PATIENT WITH COSTELLO SYNDROME: LITERATURE REVIEW AND CLINICAL CASE

  • A.N. Zavyalova Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100 http://orcid.org/0000-0003-3501-9660
  • I.A. Lisitsa Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
  • O.V. Lisovsky Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
  • A.I. Osipov Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
Keywords: Costello syndrome; developmental delay; embryonal rhabdomyosarcoma; nutritional status

Abstract

Costello syndrome belongs to RAS-pathies and is a multisystem disease based on a heterozygous  mutation of the HRAS gene. Frequent characteristic features are a specifi c phenotype with dysmorphic facial features, delayed mental and psychomotor development, and a tendency to develop neoplasms. The biphasic growth of patients with the development of severe nutritional defiiency after birth causes diffi culties in correcting the trophological status. A wide range of diseases included in the range of diff erential diagnosis with polymorphism of the clinical picture of the disease can cause diffi culties in early diagnosis and adequate therapy. The article provides a review of the literature devoted to the analysis of the mechanisms of development of Costello syndrome, as well as a 4-year observation of a patient whose clinical picture consisted of mental retardation, impaired psychomotor and physical development, severe protein-energy deficiency, dermatological complications, as well as the development of embryonic rhabdomyosarcoma of the bladder.

References

Габитова Н.Х., Казакова Ф.М., Хакимова Р.Н. Случай редкого заболевания у новорожденного ребенка. Практическая медицина. 2012; 9(65): 185–7.

Karnoub A.E., Weinberg R.A. Ras oncogenes: split personalities. Nature reviews. Molecular cell bio­logy. 2008; 9(7): 517–31. DOI: 10.1038/nrm2438.

Dard L., Hubert C., Esteves P. et al. HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models. The Journal of clinical investigation. 2022; 132(8): e131053. DOI: 10.1172/JCI131053.

Васина Т.Н., Зубцова Т.И., Ставцева С.Н. и др. Клиническая диагностика редкого наследственного заболевания — синдрома Костелло. Российский вестник перинатологии и педиатрии. 2010; 5: 27–30.

Vurallia D., Kosukcub C., Taskiranb E. et al. Hyperinsulinemic hypoglycemia in a patient with Costello syndrome: an etiology to consider in hypoglycemia. Molecular syndromology. 2020; 11: 207–16. DOI: 10.1159/000510171.

Aoki Y., Niihori T., Kawame H. et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nature genetics. 2005; 37: 1038–40. DOI: 10.1038/ng1641.

Харитонова Н.А., Басаргина М.А., Митиш М.Д. и др. Синдром Костелло в практике неонатолога. Клинический случай. Медицинский оппонент. 2021; 4(16): 76–80.

Costello J.M. A new syndrome: mental subnormality and nasal papillomata. Australian paediatric journal. 1977; 13: 114–8. DOI: 10.1111/j.1440-1754.1977.tb01135.x.

Peixoto I.L., Carreno A.M., Prazeres V.M. et al. Syndrome in question. Costello syndrome. Anais brasileiros de dermatologia. 2014; 89(6): 1005–6. DOI: 10.1590/abd1806-4841.20143062.

Hinek A., Teitell M.A., Schoyer L. et al. Myocardial storage of chondroitin sulfate-containing moieties in Costello syndrome patients with severe hypertrophic cardiomyopathy. American journal of medical genetics. 2005; 133A(1): 1–12. DOI: 10.1002/ajmg.a.30495.

Privitera S., Prody C.A., Callahan J.W. et al. The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein. The Journal of biological chemistry. 1998; 273(11): 6319–26. DOI: 10.1074/jbc.273.11.6319.

Gripp K.W., Morse L.A., Axelrad M. et al. Costello syndrome: Clinical phenotype, genotype, and mana­gement guidelines. American journal of medi­cal genetics. 2019; 179(9): 1725–44. DOI: 10.1002/ajmg.a.61270.

Gripp K.W., Lin A.E., Nicholson L. et al. Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome. American journal of medical genetics. 2007; 143A: 1472–80. DOI: 10.1002/ajmg.a.31815.

Gripp K.W., Hopkins E., Sol-Church K. et al. Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C. American journal of medical genetics. 2011; 155A: 706–16. DOI: 10.1002/ajmg.a.33884.

McCormick E.M., Hopkins E., Conway L. et al. Assessing genotype-phenotype correlation in Costello syndrome using a severity score. Genetics in medicine: official journal of the American College of Medical Genetics. 2013; 15: 554–7. DOI: 10.1038/gim.2013.6.

Kerr B., Delrue M.-A., Sigaudy S. et al. Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. Journal of medical genetics. 2006; 43: 401–5. DOI: 10.1136/jmg.2005.040352.

Martin R.A., Jones K.L. Delineation of the Costello syndrome. American journal of medical genetics. 1991; 41: 346–9. DOI: 10.1002/ajmg.1320410316.

Der Kaloustian V.M., Moroz B., McIntosh N. et al. Costello syndrome. American journal of medi­cal genetics. 1991; 41: 69–73. DOI: 10.1002/ajmg.1320410118

Okamoto N., Chiyo H., Imai K. et al. A Japanese patient with the Costello syndrome. Human genetics. 1994; 93: 605–6. DOI: 10.1007/BF00202834.

Schwartz D.D., Katzenstein J.M., Highley E.J. et al. Age-related differences in prevalence of autism spectrum disorder symptoms in children and adolescents with Costello syndrome. American journal of medical genetics. 2017; Part A, 173(5): 1294–1300. DOI: 10.1002/ajmg.a.38174.

Young O., Perati S., Weiss L.A. et al. Age and ASD symptoms in Costello syndrome. American journal of medical genetics. 2018; Part A, 176(4): 1027–8. DOI: 10.1002/ajmg.a.38641.

Leoni C., Romeo D.M., Pelliccioni M. et al. Musculo-skeletal phenotype of Costello syndrome and cardio-facio-cutaneous syndrome: insights on the functional assessment status. Orphanet journal of rare diseases. 2021; 16(1): 43. DOI: 10.1186/s13023-021-01674-y.

Qian W., Zhang M., Huang H. et al. Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review. Molecular genetics & geno­mic medicine. 2021; 9(6): e1690. DOI: 10.1002/mgg3.1690.

Di Rocco M., Gatti R., Gandullia P. et al. Report on two patients with Costello syndrome and sialuria. American journal of medical genetics. 1993; 47(7): 1135–40. DOI: 10.1002/ajmg.1320470737.

Gripp K.W., Rauen K.A. Costello syndrome. Gene Reviews. 2020: 1–29.

Zampino G., Pantaleoni F., Carta C. et al. Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome. Human mutation. 2007; 28(3): 265–72. DOI: 10.1002/humu.20431.

Umans S., Decock P., Fryns J.P. Costello syndrome: the natural history of a true postnatal growth retardation syndrome. Genetic counseling. 1995; 6(2): 121–5.

Fryns J.P., Vogels A., Haegeman J. et al. Costello syndrome: a postnatal growth retardation syndrome with distinct phenotype. Genetic counseling. 1994; 5(4): 337–43.

Costello J.M. Costello syndrome: update on the original cases and commentary. (Letter). American journal of medical genetics. 1996; 62(2): 199–201. DOI: 10.1002/ajmg.1320620203.

Kawame H., Matsui M., Kurosawa K. et al. Further delineation of the behavioral and neurologic features in Costello syndrome. American journal of medical genetics. 2003; 118A(1): 8–14. DOI: 10.1002/ajmg.a.10236.

Leoni C., Giorgio V., Onesimo R. et al. Impact of Costello syndrome on growth patterns. Am Ame­rican journal of medical genetics. 2020; Part A, 182(11): 2797–9. DOI: 10.1002/ajmg.a.61812.

Ishida S., Mutsuga M., Fujita T. et al. Surgical techniques for infectious endocarditis of the mitral valve with hypertrophic cardiomyopathy in Costello syndrome. Journal of cardiology cases. 2022; 25(6): 367–9. DOI: 10.1016/j.jccase.2021.12.010.

Lin A.E., Rauen K.A., Gripp K.W. et al. Clarification of previously reported Costello syndrome patients. (Letter). American journal of medical genetics. 2008; Part A, 146A(7): 940–3. DOI: 10.1002/ajmg.a.32164.

Smith L.P., Podraza J., Proud V.K. Polyhydramnios, fetal overgrowth, and macrocephaly: prenatal ultrasound findings of Costello syndrome. American journal of medical genetics. 2009; Part A, 149A(4): 779–84. DOI: 10.1002/ajmg.a.32778.

Torrelo A., Lopez-Avila A., Mediero I.G. et al. Costello syndrome. Journal of the American Academy of Dermatology. 1995; 32(5 Pt 2): 904–7. DOI: 10.1016/0190-9622(95)91559-1.

Gripp K.W., Lin A.E. Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations. Genetics in medicine: official journal of the American College of Medical Genetics. 2012; 14(3): 285–92. DOI: 10.1038/gim.0b013e31822dd91f.

Leoni C., Flex E. Costello Syndrome: The Challenge of Hypoglycemia and Failure to Thrive. EBioMedicine. 2018; 27: 5–6. DOI: 10.1016/j.ebiom.2017.12.006.

Leoni C., Onesimo R., Giorgio V. et al. Understanding growth failure in Costello syndrome: increased res­ting energy expenditure. The Journal of pediatrics. 2016; 170: 322–4. DOI: 10.1016/j.jpeds.2015.11.076.

Sánchez-Montenegro C., Vilanova-Sánchez A., Barrena-Delfa S. et al. Costello Syndrome and Umbilical Ligament Rhabdomyosarcoma in Two Pediatric Patients: Case Reports and Review of the Literature. Case reports in genetics. 2017: 1587610. DOI: 10.1155/2017/1587610.

Feingold M. Costello syndrome and rhabdomyosarcoma. (Letter). Journal of medical genetics. 1999; 36(7): 582–3.

Kerr B., Eden O.B., Dandamudi R. et al. Costello syndrome: two cases with embryonal rhabdomyosarcoma. Journal of medical genetics. 1998; 35(12): 1036–9. DOI: 10.1136/jmg.35.12.1036.

Gripp K.W., Scott C.I., Nicholson L. et al. Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol. American journal of medical genetics. 2002; 10(1): 80–7. DOI: 10.1002/ajmg.10241.

Menke J., Pauli S., Sigler M. et al. Uniparental trisomy of a mutated HRAS proto-oncogene in embryonal rhabdomyosarcoma of a patient with Costello syndrome. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2015; 33(13): e62–5. DOI: 10.1200/JCO.2013.49.6539.

Moroni I., Bedeschi F., Luksch R. et al. Costello syndrome: a cancer predisposing syndrome? Clinical dysmorphology. 2000; 9(4), 265–8. DOI: 10.1097/00019605-200009040-00006.

Franceschini P., Licata D., Di Cara G. et al. Bladder carcinoma in Costello syndrome: report on a patient born to consanguineous parents and review. American journal of medical genetics. 1999; 86(2): 174–9.

Gripp K.W., Scott C.I., Nicholson L. et al. Second case of bladder carcinoma in a patient with Costello syndrome. (Letter). American journal of medical genetics. 2000; 90(3): 256–9. DOI: 10.1002/(sici)1096-8628(20000131)90:3<256::aid-ajmg16>3.0.co;2-d.

Lin A.E., O’Brien B., Demmer L.A. et al. Prenatal features of Costello syndrome: ultrasonographic fndings and atrial tachycardia. Prenatal diagnosis. 2009; 29(7): 682–90. DOI: 10.1002/pd.2276.

Leoni C., Viscogliosi G., Tartaglia M. et al. Multidisciplinary Management of Costello Syndrome: Current Perspectives. Journal of multidisciplinary healthcare. 2022; 15: 1277–96. DOI: 10.2147/JMDH.S291757.

Published
2024-03-19
How to Cite
Zavyalova, A., Lisitsa, I., Lisovsky, O., & Osipov, A. (2024). PATIENT WITH COSTELLO SYNDROME: LITERATURE REVIEW AND CLINICAL CASE. Children’s Medicine of the North-West, 11(4), 99-109. https://doi.org/10.56871/CmN-W.2023.61.17.012
Section
Статьи